Medications

First biosimilar approved to treat multiple sclerosis

The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.

Diseases, Conditions, Syndromes

Chimera viruses can help the fight against lymphomas

Researchers from Instituto de Medicina Molecular (iMM) Lisboa have created a chimera virus that allows the study of molecules to treat cancers caused by human herpes virus infection in mice models of disease.

Immunology

Researchers identify master molecule behind corneal inflammation

One of the symptoms of herpes simplex virus-1 infection of the eye is lingering inflammation of the cornea - the clear outer layer of the eyeball. But without blood vessels, it has long puzzled researchers how this tissue ...

Diseases, Conditions, Syndromes

Exploring why viruses cause lesions and rashes

Early in 2024, reports of a fatal case of Alaskapox were circulating in the news. A little-known virus with few cases to its name, Alaskapox virus triggers the eruption of 1 or more skin lesions on the body, among other symptoms. ...

page 2 from 2